EIT Health announced their support for two innovator teams following their 2021 Wild Card programme, selecting PeriVision and INVENTION. The two teams, from Switzerland and Sweden respectively, will now be further supported by EIT Health (which is backed by the EU as part of the European Institute of Innovation and Technology) over the next two years.
These updates are republished press releases and communications from members of the Science|Business Network
EIT Health’s S4DX raises 5 million euros to digitise blood sampling
• Company was founded as part of EIT Health Wild Card programme in 2018 and received 2 million euros from the EU-backed healthcare innovation network
• Latest series A fundraising round comes from private investors including SARSTEDT AG & Co. KG as well as the European Innovation Council (EIC)
Today, EIT Health-backed S4DX has announced the successful closing of five million euros in series A fundraising. The funding comes from private investors including SARSTEDT AG & Co. KG, as well as the EIC Fund, established in 2020 by the European Commission for direct equity investment in breakthrough technologies, and will be used to further accelerate the market entry of S4DX’s innovative blood sampling system.